BlackBarn Capital Partners’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.04M | Buy |
2,603,521
+261,650
| +11% | +$808K | 0.46% | 15 |
|
|
2025
Q1 | $8.17M | Hold |
2,341,871
| – | – | 0.52% | 12 |
|
|
2024
Q4 | $7.66M | Buy |
2,341,871
+270,971
| +13% | +$886K | 0.42% | 12 |
|
|
2024
Q3 | $7.97M | Hold |
2,070,900
| – | – | 1.05% | 12 |
|
|
2024
Q2 | $6.4M | Hold |
2,070,900
| – | – | 0.57% | 15 |
|
|
2024
Q1 | $5.34M | Buy |
+2,070,900
| New | +$5.34M | 3.02% | 14 |
|